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CHAPTER I 
In this chapter, a brief introduction to the biological activity of 2H-1-benzopyran-2-ones, 
Quinazolines, Quinazolinones, Selenadiazolo benzimidazoles, Thiadiazolo benzimidazoles, 
Selenadiazolo Xathones, Hexahydroxathenes, Pyrazoles and Dihydropyrimidin-2(1H)-ones is 
discussed. The above molecules are important in medicinal applications and they are 
incorporated in several drugs. Applications of these drugs prompted to synthesize the 
heterocyclic molecules by employing new reagents under conventional method and also under 
green techniques like solid state method and microwave irradiation. 
Among these three methods, microwave irradiation and solid state methods are more 
advantageous than conventional method, because microwave irradiation has been extensively 
used for the rapid synthesis of a variety of heterocyclic compounds, due to short reaction times 
and increase of yields with high purity. The microwave reactions are believed to meet the 
demands of green chemistry. On the other hand, solid state method is the more useful method 
since, avoiding the solvent, friendly to the environment and yields are excellent with high purity. 
For the synthesis of these heterocyclic compounds, various reagents were used such as cellulose 
sulfuric acid and xanthan sulfuric acid. 
 
Cellulose Sulfuric Acid (CSA): 
        
Cellulose is one of the most abundant natural biopolymers and has been studied during the past 
several decades because it is a biodegradable material and a renewable resource. Its unique 
properties make it an attractive alternative to conventional organic or inorganic supports in 
catalytic applications.  
 
SO3HCellulose
 
Xanthan Sulfuric Acid (XSA): 
 
Xanthan and its derivatives have some unique properties, which make them attractive 
alternatives for conventional organic or inorganic supports for catalytic applications. Xanthan is  
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the most abundant bacterial exopolysaccharide in the world, which is produced through 
fermentation. It has been widely studied during the past decades, as it is a biodegradable material 
and a renewable resource. Unlike other gums, it is very stable under a wide range of 
temperatures and pH values. 
SO3HXanthan
 
 
CHAPTER-II 
Section-A 
 
Synthesis of 3-[Benzimidazo- and benzothiadiazoleimidazo-(1,2-c) 
quinazolin-5-yl]-2H-chromene-2-ones using Conventonal Method and 
Microwave Irradiation 
 
Over a century the quinazoline moiety has been portrayed as an important heterocycle in 
medicinal chemistry, due to its wide range of biological properties, such as anticancer, 1-3 
antiviral 4-5 and antimicrobial activities 6 etc. A series of 3-[benzimidazo(1,2-c)quinazolin-5-yl]-
2H-chromene-2-one (6a-6f) and 3-[benzothiadiazoleimidazo(1,2-c)quinazolin-5-yl]-2H-
chromene-2-one (7a-7f) derivatives that incorporate a variety of substituents at 6- and/or 8- 
positions of the coumarin moieties has been synthesized by the condensation of 2-(2-oxo-2H-
chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-one with o-phenylene diamine or benzo[c][1,2,5] 
thiadiazole-4,5-diamine utilizing cellulose sulfuric acid as an efficient catalyst under both 
conventional heating and microwave irradiation procedures.   
 
2-oxo-2H-chromene-3-carboxylic acids (3a-3f) 
 To the solution of simple and substituted salicylaldehydes and malonic acid in ethanol, aniline 
was added. The mixture was kept aside for 24 hr. and then treated with 2N HCl solution which 
afforded corresponding coumarin-3-carboxylic acids.  
OH
CHO
R1
R2
C6H5NH2
24 hrs/ rt
O O
COOH
R1
R2
HOOC
HOOC
1a-1f 2 3a-3fScheme-1
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2-oxo-2H-chromene-3-carbonyl chlorides (4a-4f) 
Coumarin-3-carboxylic acid was treated with thionyl chloride in the presence of benzene as a 
solvent at reflux temperature for about 1 hr. After completion of the reaction, the solvent was 
removed by distillation which afforded 2-oxo-2H-chromene-3-carbonyl chlorides. 
SOCl2/Benzene
Reflux
O O
COOH
R1
R2
O O
COCl
R1
R2
3a-3f 4a-4fScheme-2
 
2-(2-oxo-2H-chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-ones (5a-5f) 
 
Anthranilic acid was treated with substituted 2-oxo-2H-chromene-3-carbonyl chlorides (4a-4f) in  
pyridine at 110 oC for 6-8 hrs which afforded  2-(2-oxo-2H-chromen-3-yl)-4H-
benzo[d][1,3]oxazin-4-ones. 
4a-4f Scheme-3
O O
Cl
O
COOH
NH2 Pyridine
N
O
O
OO
110 oC /
R1
R2
R1
R26-8 hr
8 5a-5f
 
 
Synthesis of 3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones (6a-6f) 
 
o-phenylenediamine was treated with 2-(2-oxo-2H-chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-
ones (5a-5f)  in the presence of cellulose sulfuric acid in DMF under microwave irradiation or 
under reflux conditions which furnished the corresponding substituted 3-[benzimidazo(1,2-
c)quinazolin-5-yl]-2H-chromene-2-ones (6a-6f) (Scheme-4) 
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Synthesis of 3-[benzothiadiazoleimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones (7a-7f) 
 
Benzo[c][1,2,5]-thiadiazole-4,5-diamine was treated with 2-(2-oxo-2H-chromen-3-yl)-4H-
benzo[d][1,3]oxazin-4-ones (5a-5f) in the presence of cellulose sulfuric acid in DMF under 
microwave irradiation or under reflux conditions which furnished the corresponding substituted 
3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones (7a-7f) (Scheme-5) 
N
N
N
OO
N
O
O
OO
R1
R2
R1
R2
+
NH2
NH2
a or b
5a-5f 9 6a-6fScheme-4
 
N
N
N
OO
N
O
O
OO
R1
R2
R1
R2
+
NH2
NH2
NS
N
N
SN
a or b
5a-5f 10 7a-7fScheme-5
 
Compound         R1         R2            Compound         R1          R2
6a          H            H                     7a              H           H
6b          Br           H                   7b               Br            H
6c          Cl         Cl                   7c               Cl           Cl
6d          Br         Br                  7d               Br           Br
6e         CH3       H                   7e               CH3         H
6f           H         NO2                7f                H           NO2
 
 
Reagents and conditions: (a) Method A: cellulose sulfuric acid, DMF, microwave irradiation, 
5-6 min, 91-97% yield; (b) Method B: cellulose sulfuric acid, DMF, reflux, 5-6 hours, 79-86% 
yield.               
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CHAPTER-II 
Section-B 
 
Synthesis of 2-(2-oxo-2H-chromen-3-yl)-3-arylquinazolin-4(3H)-ones using 
Conventonal Method and Microwave Irradiation 
 
Quinazolinones are an important class of bio-active drug targets in the pharmaceutical industry, 
as they are the core structure of numerous biologically active compounds 7. A series of novel 
quinazolin-4(3H)-one derivatives was synthesized by the reaction between 2-(2-oxo-2H-
chromen-3-yl)-4H-benzo[d] [1,3]oxazin-4-one and substituted amines by using xanthan sulfuric 
acid as a solid acid catalyst. All the compounds were characterized by spectral data.  
 
2-(2-oxo-2H-chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-ones 
 
Anthranilic acid was treated with substituted 2-oxo-2H-chromene-3-carbonyl in pyridine at 
110oC for 6-8 hrs which afforded corresponding 2-(2-oxo-2H-chromen-3-yl)-4H-
benzo[d][1,3]oxazin-4-ones. 
1 Scheme-1
O O
Cl
O
COOH
NH2 Pyridine
N
O
O
OO
110 oC /
R1
R2
R1
R26-8 hr
2 3
 
Synthesis of 2-(2-oxo-2H-chromen-3-yl)-3-arylquinazolin-4(3H)-ones         
Microwave Irradiation  
Mixture of 2-(2-oxo-2H-chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-one, substituted amines and 
Xanthan sulfuric acid in DMF was taken in an open vessel, placed in microwave oven and 
irradiated at 300 watt power level for 5-6 min.  
 
Conventional Method 
Mixture of 2-(2-oxo-2H-chromen-3-yl)-4H-benzo[d][1,3]oxazin-4-one, substituted amines and 
Xanthan sulfuric acid in DMF was refluxed for 3-4 hr.  
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R2
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Compound    R      R1     R2            Compound      R      R1   R2
      
      4a          H        H       H                   4f             H      H      NH2
      4b         Br        H      NO2               4g            Cl     Cl     Cl
      4c         Cl      Cl     OCH3             4h              Br     H     OCH3
      4d         Cl      Cl     NH2                4i             Br     H     Cl
      4e         Cl      Cl     NO2
 
 
CHAPTER-III 
Section-A 
 
Synthesis of Selenadiazolo Benzimidazoles using Conventonal Method and 
Microwave Irradiation 
 
Benzimidazole is a heterocyclic aromatic organic compound. This bicyclic compound consists of 
the fusion of benzene and imidazole. An efficient and eco-friendly method has been developed 
for the synthesis of selenadiazolo benzimidazoles by the condensation of N-
benzylbenzo[c][1,2,5]selenadiazole-4,5-diamine with various aromatic aldehydes catalyzed by 
xanthan sulfuric acid.  
 
N-benzylbenzo[c][1,2,5]selenadiazole-4,5-diamine (5)  
The first step involves the Hinsberg reaction 8 for the synthesis of the corresponding 4-chloro 
selenadiazole, this on nitration, followed by amination and then treated with sodium dithionate in 
boiled water which afforded N-benzylbenzo[c][1,2,5]selenadiazole-4,5-diamine. 
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Synthesis of Selenadiazolo benzimidazoles 
Method-A (microwave irradiation) 
Mixture of N-benzylbenzo[c][1,2,5]selenadiazole-4,5-diamine, aldehyde and Xanthan sulfuric 
acid in chloroform was taken in an open vessel, placed in microwave oven and irradiated at 450 
watt power level for 8 min. 
Method-B (conventional method) 
Mixture of N-benzylbenzo[c][1,2,5]selenadiazole-4,5-diamine, aldehyde and Xanthan sulfuric 
acid in chloroform was stirred at room temperature for 4 hr. 
Scheme-2
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CHAPTER-III 
Section-B 
 
Synthesis of Thiadiazolo Benzimidazoles under Solid State Conditions in 
Biodegradable Cellulose Sulfuric Acid  
             
An efficient method for the synthesis of 2-substituted benzimidazoles has been developed. In this 
method, benzo[c][1,2,5]thiadiazole-4,5-diamine was condensed with an aromatic aldehyde in the 
presence of cellulose sulfuric acid
 
under solvent-free conditions by simple physical grinding of 
reactants using a mortar and pestle at room temperature.  
 
Benzo[c][1,2,5]thiadiazole-4,5-diamine (5)  
o-Phenylenediamine was treated with thionyl chloride in the presence of pyridine and dry 
chloroform refluxed for 90 min which furnished benzo[c][1,2,5]thiadiazole (2), this on nitration, 
followed by amination and then treated with sodium dithionate in boiled water which afforded 
benzo[c][1,2,5]thiadiazole-4,5-diamine 9. 
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Scheme-1
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Thiadiazolo benzimidazole (7a-7n)  
Synthesis of Thiadiazolo benzimidazoles by simple physical grinding of benzo[c][1,2,5] 
thiadiazole-4,5-diamine, different aldehydes and Cellulose sulfuric acid
 
using a mortar and pestle 
at room temperature.  After completion of the reaction, ethyl acetate was added and the reaction 
mixture was washed with water. The organic layer was dried over anhydrous sodium sulphate 
and concentrated to dryness, and the crude solid product was further purified by column 
chromatography. 
Scheme-2
NH2
NH2
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N
CHO
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R.T, 2 min
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H
N
R R
5 7a-7k6
 
H
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CHAPTER-IV 
Section-A 
 
Synthesis of 11H-xantheno [2, 1-c] [1, 2, 5] selenadiazol-11-ones  
using Conventonal Method and Microwave Irradiation 
 
Xanthones are exhibiting a broad spectrum of biological activities.10 Xanthone is usually 
assembled from its constituent fragments to form the middle pyranone ring. A series of 11H-
xantheno [2, 1-c] [1, 2, 5] selenadiazol-11-one derivatives (6a-6i) that incorporate a variety of 
substituents has been synthesized under both conventional heating and microwave irradiation 
procedures.  
 
5-chloro-4-nitrobenzo[c][1,2,5]selenadiazole (3)  
Compound 1 was treated with selenium dioxide in dry chloroform stirred for 30 min which 
afforded 4-chloro selenadiazole followed by nitration furnished the final product (3).  
Scheme-1
N
Se
N
NO2
Cl
N
Se
NCl HNO3+H2SO4
O 0C
2 31
NH2
NH2Cl SeO2
dry CHCl3
 
 
Synthesis of 11H-xantheno [2, 1-c] [1, 2, 5] selenadiazol-11-one  
 
Method-A (microwave irradiation) 
Mixture of 5-chloro-4-nitrobenzo[c][1,2,5]selenadiazole, substituted salicylaldehyde and 
piperdine in ethanol was taken in an open vessel, placed in microwave oven and irradiated at 450 
watt power level for 5-6 min. 
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Method-B (conventional method) 
Mixture of 5-chloro-4-nitrobenzo[c][1,2,5]selenadiazole, substituted salicylaldehyde and 
piperdine in ethanol was refluxed for 5-6 hr. 
Scheme-2
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CHAPTER-IV 
Section-B 
 
Synthesis of 1-Oxo-hexahydroxanthenes under Solid State Conditions in 
Biodegradable Cellulose Sulfuric Acid 
 
1-Oxo-hexahydroxanthene and their derivatives have drawn much attention in the field of 
medicinal chemistry. A series of 1-Oxo-hexahydroxanthene derivatives was synthesized at room 
temperature in solid-state from substituted salicylaldehydes and substituted 1, 3-hexanediones in 
the presence of a catalytic amount of cellulose sulfuric acid. The results showed that the reaction 
performed under solid state conditions was benign to the environment, with higher yields and 
more convenient work-up.  
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Synthesis of 1-Oxo-hexahydroxanthene  
 
Mixture of salicylaldehyde, 1, 3-hexanedione and Cellulose sulfuric acid was taken in a mortar, 
and ground with a pestle at room temperature for 20-30 min. 
R4
R3
R2
OH
CHO
+
O
O
R1
R1
Cellulose sulfuric acid
R.T/  20-30 min
Grinded
O
O
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R1
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R1 R1
Scheme-11 3a-3m2
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H
H
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H
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CHAPTER-V 
Section-A 
 
Synthesis of 4,4l-(arylmethylene)bis(1H-pyrazol-5-ols) using  
Xanthan Sulfuric Acid as a Bio-Supported Acid Catalyst 
 
A simple and efficient method has been developed for the synthesis of 4,4l-
(arylmethylene)bis(1H-pyrazol-5-ols) by  the condensation reaction between substituted 
aldehydes, and 1-phenyl-3-methylpyrazol-5-one in the presence of xanthan sulfuric acid (XSA)  
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as a solid acid catalyst. This method is simple, cost effective, requires short reaction times, yields 
are excellent with high purity and the catalyst could be easily recycled.  
 
4, 4l-(arylmethylene)bis(3-methyl-1-phenyl-pyrazol-5-ols) 
A mixture of aromatic aldehyde, 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one and xanthan 
sulfuric acid in ethanol was heated under reflux for 15-30 min. 
N
N
Me
O
Ph
+
N
N
N
N
Ph PhOH OH
Me Me
Xanthan sulfuric acid
EtOH, Reflux
CHO
R
  Scheme-11 2 3a-3i
R
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4-NO2
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N
N
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O
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+
N
N
N
N
Ph PhOH OH
Me Me
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1 4 3j  Scheme-2
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CHAPTER-V 
Section-B 
 
A Simple and Convenient Pechmann Condensation in Biodegradable 
Cellulose Sulfuric Acid and Xanthan Sulfuric Acid  
 
The coumarin molecule has wide variety of applications in organic and medicinal chemistry for 
many years as a large number of natural products contain this heterocyclic nucleus and they have 
various biological properties such as antibacterial, 11 anticancer activities, 12 and inhibitory of 
HIV-1 protease. 13 The synthesis of coumarins by the condensation of phenols and ethyl 
acetoacetate via Pechmann condensation in the presence of catalysts like cellulose sulfuric acid 
and xanthan sulfuric acid under solvent free conditions was discussed in this chapter. 
 
Synthesis of Coumarins 
Method-I (by using Cellulose Sulfuric Acid) 
Mixture of phenol and β-ketoester in the presence of cellulose sulfuric acid in solvent-free media 
leading to the formation of coumarin derivatives using both conventional heating and microwave 
irradiation in excellent yields 
 
2 31
OH EtO O
R1
O
Cellulose sulfuric acid
MW  300W/ R.T
O O
R1
RR
Scheme-1
 
Method-II (by using Xanthan Sulfuric Acid) 
Mixture of phenol, β-ketoester and Xanthan sulfuric acid was stirred at room temperature for 20-
30 min afforded corresponding coumarin derivatives 
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2 31
OH EtO O
R1
O
Xanthan sulfuric acid
neat, R.T
O O
R1
RR
Scheme-2
 
 
CHAPTER-V 
Section-C 
 
Synthesis of 3, 4-dihydropyrimidin-2(1H)-ones in Bio-Supported 
 Xanthan Sulfuric Acid  
 
3,4-dihydropyrimidin-2(1H)-ones have been attracting due to their diverse therapeutic and 
pharmacological properties. 14-15 Xanthan sulfuric acid (XSA) is employed as a recyclable 
catalyst for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones. These syntheses were performed 
via a one-pot three-component condensation of aldehydes, amines, and urea/thiourea under 
solvent-free conditions.  
 
Synthesis of 3, 4-dihydropyrimidin-2(1H)-ones 
 
Mixture of aldehyde, 1, 3-dicarbonyl compound, urea or thiourea, Xanthan sulfuric acid was 
stirred at 40 oC.  
N
H
NH
X
R1
H3C
O R
R H
O
H2N NH2
X
CH3
O
O
+ +
R1
Xanthan sulfuric acid
Neat / 40 oc
1 2 3 4Scheme-1
 
 
 
          R                 R1      X                            R                   R1        X
4a    H      OEt   O                4h   4-OH     OEt     S  
4b    4-OMe   OEt   O              4i    4-OMe     OEt     S 
4c    4-NO2     OEt  O              4j    H        OMe  O
4d    4-Cl      OEt  O              4k   4-OMe     OMe   O 
4e    4-F      OEt  O              4l    4-NO2    OMe  O 
4f     2, 4-Cl    OEt  O             4m   2, 4-Cl    OMe  O 
4g    2-Br      OEt    O             4n    4-F          OMe  O
                                                           4p      C10H7                  OEt      S
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CHAPTER-VI 
Results of Biological activity of the newly synthesized compounds 
 
Biological activities of the newly synthesized compounds are briefly discussed. The compounds 
were screened for antibacterial and antifungal activity. 
 
3-[Benzimidazo- and benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-
chromene-2-ones  
 
Series of 3-[Benzimidazo- and benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-
2-ones 6a-6f & 7a-7f of Chapter-II, Section-A was evaluated for their antimicrobial activity 
against Bacillus subtilis, Staphylococcus aureus, Streptococcus pyogenes (Gram-positive 
bacteria), Escherichia Coli, Klebsiella pneumonia, Salmonella typhimurium (Gram-negative 
bacteria), and Aspergillus niger, Candida albicans, and Aspergillus flavus (Fungi). 
 
All the twelve compounds in the series exhibited antibacterial activity against both Gram-
positive and Gram-negative bacterial strains with zones of inhibition (ZOI) ranging from 20 mm 
to 50 mm. 6,8-Dichloro-3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (6c, ZOI[BS] 
= 42 mm,  ZOI[SA] = 50 mm, ZOI[SP] = 38 mm, ZOI[EC] = 44 mm, ZOI[KP] = 47 mm, and  
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ZOI[ST] = 48 mm) was identified as a potent antibacterial agent against all Gram-positive and 
Gram-negative bacterial strains. 6,8-Dibromo-3-[benzothiadiazoleimidazo(1,2-c)quinazolin-5-
yl]-2H-chromene-2-one (7d, ZOI[BS] = 41 mm,  ZOI[SA] = 48 mm, ZOI[SP] = 37 mm, ZOI[EC] = 42 
mm, ZOI[KP] = 46 mm, and ZOI[ST] = 45 mm) also showed good antibacterial activity against all  
Gram-positive and Gram-negative bacterial strains. 6, 8-Dibromo-3-[benzimidazo(1,2-c) 
quinazolin-5-yl]-2H-chromene-2-one (6d, ZOI[SP] = 36 mm, ZOI[EC] = 41 mm) also had  good 
antibacterial activity against two bacterial strains which exhibited similar antibacterial activity as 
Ampicillin, the standard antibiotic drug. 
8-Bromo-3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (6b, ZOI[AF] = 45 
mm) and 6,8-dibromo-3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (6d, ZOI[AN] = 
48 mm,  ZOI[CA] = 41 mm, and ZOI[AF] = 46 mm) were identified as the most potent antifungal 
agents against all three fungal strains. The 6-nitro-3-[benzothiadiazoleimidazo(1,2-c)quinazolin-
5-yl]-2H-chromene-2-one analog (7f, ZOI[AF] = 44 mm) also exhibited good antifungal activity 
against A. flavus.   
 
MIC values for all the analogs examined ranged from 2.5 to 50 µg/mL. Several analogs exhibited 
superior antimicrobial activity compared to the positive control drugs, Ampicillin and 
Ketoconazole. Two analogs, 6,8-dichloro-3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-
2-one (6c, MIC[SA] = 2.5 µg/mL; MIC[ST] = 2.5 µg/mL) and 6,8-dibromo-3-
[benzothiadiazoleimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (7d, MIC[ST] = 2.5 µg/mL) 
were identified as potent antibacterial agents against both Gram-positive and Gram-negative 
bacterial strains. These analogs showed the same magnitude of antibacterial activity as 
Ampicillin, the standard antibiotic drug. 
 
The compound
 
8-bromo-3-[benzimidazo(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (6b, 
MIC[AF] = 10 µg/mL) showed good potency against A. niger [AN] and C. albicans [CA].  The 
analog, 6,8-dibromo-3-[benzimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-one (6d, MIC[AF] = 
15 µg/mL; MIC[CA] = 15 µg/mL), also exhibited good activity against A. niger [AN] and A. flavus 
[AF]. The antifungal activities of analogs 6b and 6d are superior to the antifungal drug, 
Ketoconazole. Thus, based on the MIC data, analogs 6b, 6c, 6d, and 7d were identified as the 
most potent antimicrobial agents.   
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2-(2-oxo-2H-chromen-3-yl)-3-arylquinazolin-4(3H)-ones  
 
Series of Novel quinazolin-4(3H)-one derivatives 5a-5i of chapter-II, section-B were screened 
for their in vitro antibacterial activity against Gram-positive bacterial strains (Bacillus subtilis, 
Staphylococcus aureus, and Streptococcus pyogenes), and Gram-negative bacterial strains 
(Escherichia coli, Klebsiella pneumonia, Salmonella typhimurium) and antifungal against 
Aspergillus niger, Candida albicans,  Aspergillus flavus (Fungi).  
 
Antibacterial screening for analogs and positive control was performed at a fixed 
concentration of 1000 µg/mL. All nine compounds exhibited antibacterial activity against both 
Gram-positive and Gram-negative bacterial strains with zones of inhibition (ZOI) ranging from 
20 mm to 50 mm (Table 2).  Analog 5c (ZOI[BS] = 32 mm,  ZOI[SA] = 40 mm, ZOI[SP] = 30 mm, 
ZOI[EC] = 34 mm, ZOI[KP] = 36 mm, and ZOI[ST] = 39 mm) was identified as a potent antibacterial 
agent against all Gram-positive and Gram-negative bacterial strains. Analogs (5a-5i) were also 
examined for their antifungal activity against different fungal strains, i.e. Aspergillus niger [AN], 
Candida albicans [CA], and Aspergillus flavus [AF]. The antifungal drug Ketoconazole was 
used as a positive control. Antifungal screening for analogs and positive control was performed 
at a fixed concentration of 1000 µg/mL. Analogs, 5c (ZOI[AF] = 30 mm ) and 5d (ZOI[AN] = 35 
mm, ZOI[CA] = 33 mm, were identified as the most potent antifungal agents against all three 
fungal strains. 
 
The MIC values for all the analogs examined ranged from 2.5 to 50 µg/mL. Several 
analogs exhibited superior antimicrobial activity compared to the positive control drugs, 
Ampicillin and Ketoconazole.  Analogs, 5c (MIC[BS] = 2.5 µg/mL; MIC[SA] = 5 µg/mL, MIC[SP] = 
15 µg/mL, MIC[EC] = 10 µg/mL, MIC[KP] = 15 µg/mL,  MIC[ST] = 2.5 µg/mL) and 5d (MIC[EC] = 
10 µg/mL) were  identified as potent antibacterial agents, and two analogs,
 
5d (MIC[AF] = 10 
µg/mL; MIC[CA] = 15 µg/mL) and 5h (MIC[AF] = 10 µg/mL) were identified as potent antifungal 
agents. Based on the MIC data, analogs 5c, 5d and 5h were identified as the most potent 
antimicrobial agents.  
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Selenadiazolo benzimidazoles 
 
Series of Selenadiazolo benzimidazoles 7a–7j of chapter-III, section-A was evaluated for in 
vitro antibacterial activity against Gram-positive bacterial strains (Bacillus subtilis, 
Staphylococcus aureus, and Streptococcus pyogenes), and Gram-negative bacterial strains 
(Escherichia coli, Klebsiella pneumonia, Salmonella typhimurium) and antifungal against 
Aspergillus niger, Candida albicans, Aspergillus flavus (Fungi). 
 
Antibacterial screening for analogs and positive control was performed at a fixed 
concentration of 1000 µg/mL. All ten compounds exhibited antibacterial activity against both 
Gram-positive and Gram-negative bacterial strains with zones of inhibition (ZOI) ranging from 
15 mm to 50 mm (Table 1).  Analog 7i (ZOI
 [BS] = 40 mm, ZOI [SA] = 50 mm, ZOI [SP] = 39 mm, 
ZOI[EC] = 44 mm, ZOI[KP] = 47 mm, and ZOI[ST] = 46 mm) was identified as a potent antibacterial 
agent against all Gram-positive and Gram-negative bacterial strains. AnalogS, 7i (ZOI[AN] = 38 
mm, ZOI[CA] = 35 mm, and ZOI[AF] = 38 mm), 7d (ZOI[CA] = 35 mm ZOI[AF] = 38 mm) and 7j 
(ZOI[CA] = 35 mm) were identified as the most potent antifungal agents against all three fungal 
strains. 
The MIC values for all the analogs examined ranged from 2.5 to 50 µg/mL. Several 
analogs exhibited superior antimicrobial activity compared to the positive control drugs, 
Ampicillin and Ketoconazole.  Analogs, 7i (MIC[BS] = 2.5 µg/mL; MIC[SA] = 2.5 µg/mL MIC[SP] 
= 5 µg/mL, MIC[EC] = 2.5 µg/mL, MIC[KP] = 15 µg/mL, MIC[ST] = 10 µg/mL), 7e (MIC[ST] = 10 
µg/mL);  and 7j (MIC[ST] = 10 µg/mL)  were  identified as potent antibacterial agents, and 
analogs, 7i (MIC[AN] = 15 µg/mL , MIC[CA] = 15 µg/mL ,MIC[AF] = 10 µg/mL), 7j (MIC[AN] = 15 
µg/Ml, MIC[CA] = 15 µg/mL, MIC[AF] = 10 µg/mL;), 7h (MIC[AF] = 10 µg/Ml) and 7d (MIC[AF] = 
10 µg/mL) were identified as potent antifungal agents. Based on the MIC data, analog 7i was 
identified as the most potent antimicrobial agent.   
 
Selenadiazolo Xanthones 
Series of 11H-xantheno [2, 1-c] [1, 2, 5] selenadiazol-11-ones 5a-5i of chapter-IV, section-A 
was evaluated for their antimicrobial activity against. Bacillus subtilis, Staphylococcus aureus, 
Staphylococcus epidermidis (Gram-positive bacteria) Escherichia coli, Pseudomonas aeruginosa  
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Klebsiella pneumonia (Gram-negative bacteria) Candida albicans, Candida rugosa, Rhizopus 
oryzae, Aspergillus niger (Fungi). 
The antibiotic drug Penicillin was also used as a positive control. Antibacterial screening 
for analogs and positive control was performed at a fixed concentration of 1000 µg/mL. All the 
nine compounds exhibited antibacterial activity against both Gram-positive and Gram-negative 
bacterial strains with zones of inhibition (ZOI) ranging from 20 mm to 50 mm. Analogs, 5c 
(ZOI[BS] = 41 mm,  ZOI[SA] = 45 mm and ZOI[SE] = 39 mm), 5a (ZOI[SE] = 38 mm) and 5b 
(ZOI[BS] = 40 mm) were identified as potent antibacterial agents against all Gram-positive and 
Gram-negative bacterial strains.  Analogs, 5c (ZOI[EC] = 50 mm, ZOI[PA] = 40 mm and ZOI[KP] = 
46 mm) and 5a (ZOI[KP] = 45 mm) also showed good antibacterial activity against all Gram-
positive and Gram-negative bacterial strains. Analogs, 5c (ZOI[CA] = 47 mm, ZOI[CR] = 46 mm, 
ZOI[RO] = 40 mm,  and ZOI[AN] = 39 mm), 5b (ZOI[CR] = 45 mm, and ZOI[RO] = 38 mm), 5a 
(ZOI[AN] = 39 mm), and 5c (ZOI[AN] = 39 mm) were identified as the most potent antifungal 
agents against all three fungal strains.  
 
Analog, 5c (MIC[BS] = 2.5 µg/mL; MIC[SA] = 10 µg/mL; MIC[SE] = 2.5 µg/mL; MIC[EC] = 
5 µg/mL; MIC[PA] = 10 µg/mL; MIC[KP] = 2.5 µg/mL) was identified as potent antibacterial 
agent, and analogs,
 
5c (MIC[CA] = 15 µg/mL; MIC[CR] = 15 µg/mL and MIC[RO] = 10 µg/mL), 5b 
(MIC[AN] = 15 µg/mL) and 5a (MIC[RO] = 15 µg/mL) were identified as potent antifungal agents. 
Based on the MIC data, analogs 5a, 5b, and 5c were identified as the most potent antimicrobial 
agents.   
  
Anticancer Activity 
Selenadiazolo xanthones  
Series of Selenoxanthones was screened for their anticancer activity at National Cancer Institute, 
Bethseda, USA on several cancer cell lines like Leukemia, Non-small cell lung Cancer, Colon 
Cancer, CNS Cancer, Melanoma, Ovarian Cancer, Renal Cancer, Prostate Cancer and Breast 
Cancer. Out of the nine compounds, comp 6b is screened at single dose level activity. None of 
the compounds was selected for five dose level. 
 
